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Abstract
Background: The RNA-dependent RNA polymerase of Influenza A virus is a determinant of viral
pathogenicity and host range that is responsible for transcribing and replicating the negative sense
segmented viral genome (vRNA). Transcription produces capped and polyadenylated mRNAs
whereas genome replication involves the synthesis of an alternative plus-sense transcript (cRNA)
with unmodified termini that is copied back to vRNA. Viral mRNA transcription predominates at
early stages of viral infection, while later, negative sense genome replication is favoured. However,
the "switch" that regulates the transition from transcription to replication is poorly understood.
Results: We show that temperature strongly affects the balance between plus and minus-sense
RNA synthesis with high temperature causing a large decrease in vRNA accumulation, a moderate
decrease in cRNA levels but (depending on genome segment) either increased or unchanged levels
of mRNA. We found no evidence implicating cellular heat shock protein activity in this effect
despite the known association of hsp70 and hsp90 with viral polymerase components.
Temperature-shift experiments indicated that polymerase synthesised at 41°C maintained
transcriptional activity even though genome replication failed. Reduced polymerase association
with viral RNA was seen in vivo and in confirmation of this, in vitro binding assays showed that
temperature increased the rate of dissociation of polymerase from both positive and negative sense
promoters. However, the interaction of polymerase with the cRNA promoter was particularly heat
labile, showing rapid dissociation even at 37°C. This suggested that vRNA synthesis fails at elevated
temperatures because the polymerase does not bind the promoter. In support of this hypothesis,
a mutant cRNA promoter with vRNA-like sequence elements supported vRNA synthesis at higher
temperatures than the wild-type promoter.
Conclusion:  The differential stability of negative and positive sense polymerase-promoter
complexes explains why high temperature favours transcription over replication and has
implications for the control of viral RNA synthesis at physiological temperatures. Furthermore,
given the different body temperatures of birds and man, these finding suggest molecular hypotheses
for how polymerase function may affect host range.
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Background
The genome of influenza A virus consists of eight single-
stranded, negative-sense genomic RNA (vRNA) segments,
associated with nucleoprotein (NP) and the viral
polymerase complex (PB1, PB2 and PA) in the form of
ribonucleoprotein complexes (RNP) [1]. The viral RNA-
dependent RNA polymerase is responsible for both tran-
scription and replication of the viral genome, which take
place in the cell nucleus [2,3]. The first step in viral gene
expression is the transcription of the incoming vRNPs into
mRNA, through a primer-dependent process in which 5'-
capped RNA fragments of 10–15 nt are cleaved from host-
cell pre-mRNAs and used as primers [4]. The resulting
transcripts are polyadenylated at their 3' end when the
polymerase, reiteratively incorporates A residues as a
result of stalling at the polyuridine stretch [5-7] immedi-
ately adjacent to the 5' terminus of vRNA, to which the
polymerase remains bound. These mRNA transcripts,
being incomplete copies of the vRNA template, cannot
serve as substrates for replication of new vRNA molecules.
Viral genome replication is primer independent and gen-
erates full-length positive-sense cRNA transcripts, that are
not polyadenylated [8-10]. This replicative intermediate
subsequently serves as the template for synthesis of prog-
eny vRNA.
The temporal pattern of RNA production is well estab-
lished [11-15]. The replicative intermediate, cRNA, is first
detected during the early stages of viral infection, reaches
a maximum rate of synthesis prior to that of m- or vRNA
and then declines. Maximal rates of mRNA synthesis also
occur relatively early, before substantial amounts of vRNA
are made. Amplification of vRNA continues even after m-
and cRNA levels decline. Generally therefore, the early
stages of viral infection can be defined by a prevalence of
plus sense transcription, comprised mostly of mRNA with
a minority of cRNA, while at later times negative sense
replication in the form of vRNA synthesis is favoured. Var-
ious models have been proposed to explain the "switch"
that regulates the transition from transcription to replica-
tion. De novo protein synthesis, and therefore a first
round of viral transcription, is necessary for genome rep-
lication to occur [11,13]. NP is undoubtedly required for
both positive and negative sense genome replication
[10,16], but its precise role is not known [17-20]. Newly
synthesized polymerase protects the termini of cRNA mol-
ecules from nuclease attack [21], which at least partly
explains its requirement for the accumulation of cRNA.
Some studies support the hypothesis that alternative
forms of the polymerase catalyse transcription and repli-
cation, with a dimeric PB1-PA complex perhaps being the
minimum requirement for genome replication [22,23].
However, this is controversial with several other groups
finding an essential role for PB2 in transcription and rep-
lication [24-26]. Host cell polypeptides may also be
involved in the shift to genome replication [27-30], but
this is uncertain.
Understanding the determinants of species tropism for
influenza virus has never been more important than it is
now, with the concern about the potential of avian H5N1
virus to adapt to human hosts. While tropism is a multi-
faceted and complex process, it has long been hypothe-
sized that something as simple as the temperature at the
site of replication could influence the host and tissue tro-
pism of the virus [31-33]. Human-tropic influenza viruses
are considered to replicate in the upper respiratory tract at
33–37°C, while avian influenza viruses replicate in the
gut around 41°C [32]. The polymerase is an important
determinant of influenza virus host range and pathogenic-
ity [34-39] that is likely to be influenced by temperature.
Firstly it is a multifunctional enzyme, and secondly, the
consequence of its interaction with the 5' and 3' termini
of viral RNA is modulated by whether these regions are in
a base-paired or single stranded conformation [40]. We
therefore examined the temperature dependency of
polymerase function for mammalian adapted virus strains
in cell culture and in vitro assay systems. We found that
vRNA synthesis was markedly reduced at elevated temper-
atures, whereas mRNA synthesis was stimulated. We
found no evidence to implicate heat shock proteins in this
temperature effect, despite their known interaction with
influenza A RNPs [30,41]. The reduction of vRNA synthe-
sis correlated with a markedly increased dissociation rate
of the viral polymerase from cRNA at 41°C. Furthermore,
we find that at 37°C the interaction of polymerase with
cRNA was significantly less stable than with vRNA, a find-
ing with implications for the regulation of viral RNA syn-
thesis and for the adaptation of influenza viruses to host
species with different body temperatures.
Results
Effect of temperature on viral RNA synthesis
To test the influence of incubation temperature on viral
RNA synthesis in the context of virus infection, cells were
inoculated with influenza A/PR/8/34 (PR8) virus and
incubated at different temperatures. Infected cell lysates
were harvested every two hours until eight hours post-
infection (h.p.i.), and total cellular RNA was isolated.
Reverse transcriptase primer extension analysis using two
oligonucleotides to simultaneously detect m-, c- and
vRNA [20] was conducted to detect and measure the rela-
tive amounts of RNA produced from segment 5 (NP). A
primer extension product that presumably resulted from
cross-hybridization with a cellular RNA was observed
from all samples, infected and mock infected, at all tem-
peratures (Fig. 1A). The three expected virus specific RNA
species were synthesised in infected cells at all incubation
temperatures. Mock-infected cells did not generate any
virus specific products (Fig. 1A, lanes 17–20). At 37°CVirology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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Effect of temperature on viral RNA and protein synthesis Figure 1
Effect of temperature on viral RNA and protein synthesis. 293T cells were infected with PR8 virus or mock-infected 
(lanes 17–20) and incubated at 31°C, 37°C, 39°C or 41°C. A. Total cellular RNA was isolated at the indicated times post-infec-
tion and subjected to primer extension analysis for segment 5 transcripts. Products were separated on a 6% polyacrylamide gel 
and visualised by autoradiography. Black arrows indicate products derived from viral RNAs (as labelled). The white arrow indi-
cates a cellular derived background product. Note the generally lower levels of product in lane 5, due to a loss of that particu-
lar sample. B. Segment 1, 2, 5, 7 and 8-specific RNA from cells incubated at 37°C and 41°C was quantified at 5 h.p.i. by 
densitometry of exposed X-ray film. The amounts at 41°C are expressed as the percentage of the corresponding 37°C values. 
Mean % ± SD from 3 (segment 8), 4 (segment 1) or 5 (segments 2, 5 and 7) independent experiments are plotted. C, D. Mock-
infected (M) or infected 293T cells, incubated at either 37°C or 41°C, were pulse radiolabelled with 60 nCi/μl 35S-Methionine 
for 2 h periods ending at the indicated times p.i. before analysis by SDS-PAGE and autoradiography or (D) immunoprecipitation 
using rabbit antiserum against PB1 (α1), PB2(α2) or PA (αA). Black arrows indicate viral proteins (as labelled).Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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(lanes 5–8) the time course of viral RNA synthesis
reflected that which has been previously described in the
literature [11,13,14,20]; early synthesis of m- and cRNA
followed by late synthesis of vRNA. At 31°C, there was
less replicative RNA synthesis overall than at 37°C and the
timing of RNA production appeared to lag by 2 hours (Fig.
1A, compare lanes 2–4 to 6–8). Both m- and vRNA accu-
mulated to equivalent levels with similar timing at 39°C
compared to 37°C (Fig. 1A, compare lanes 6–8 to 10–12).
However, when infected cells were incubated at 41°C, the
levels of segment 5 vRNA were substantially decreased in
comparison to those detected at 37°C, while mRNA levels
were unchanged (Fig. 1A, compare lanes 6–8 to 14–16).
This same trend was seen when radiolabeled primer
extension products for five different segments were quan-
tified by densitometry (Fig. 1B). At 41°C on average, seg-
ment 5 mRNA accumulation at 5 h.p.i. was unchanged,
cRNA accumulation was slightly reduced, but vRNA accu-
mulation dropped by about 3-fold, compared with 37°C
incubated cells. Similar results were obtained for seg-
ments 7 (M1/M2) and 8 (NS1/NS2). Replication of seg-
ments 1 (PB2) and 2 (PB1) was even more sensitive to
high temperature, whereas mRNA levels from these two
segments were increased more than 2-fold. Thus, at high
temperature the polymerase appears to be limited to the
early pattern of transcription and unable to switch to the
late pattern of negative sense genome amplification. This
temperature effect on viral RNA synthesis was also
observed for other mammalian influenza strains, such as
A/Victoria/3/75 and A/Equine/Miami/63 (data not
shown), suggesting it is a general phenomenon for mam-
malian influenza A virus.
To test if the alteration in transcriptional balance at high
temperature resulted from differential expression of the
viral polypeptides, protein synthesis was analysed by 35S-
methionine labelling. Time course analyses of infected
cells showed similar patterns of viral protein synthesis at
37°C and 41°C (Fig. 1C, compare lanes 1–4 to lanes 6–
9). Similar levels of polypeptides of the predicted size for
HA, NP, M1, NS1 and NS2 were detected at both temper-
atures but were not present in mock-infected cells (Fig.
1C, lanes 5 and 10). Immunoprecipitation assays using
antibodies against the three subunits of the viral polymer-
ase also showed similar levels of PB1, PB2 and PA at both
temperatures (Fig. 1D, compare lanes 1–3 to 4–6). Fur-
thermore, the levels of co-precipitation of the three P pro-
teins were similar at 41°C and 37°C, suggesting the
polymerase complex is still formed at the higher tempera-
ture. No specific polypeptides were precipitated from
mock-infected cell lysates by any of the three antibodies
(lanes 7–12). The overall accumulation of PB1, M1 and
NP were also found to be similar at either temperature by
western blotting (data not shown). These results are con-
sistent with the undiminished levels of viral mRNA
observed at high temperature. Therefore, incubation of
infected cells at 41°C does not substantially alter viral
protein synthesis and the deficiency of any particular virus
protein required for genome replication is an unlikely
explanation for defective vRNA synthesis at high temper-
ature.
A plasmid based recombinant system that recreates func-
tional influenza virus RNPs in cells [3,20] was also used to
test the influence of temperature on the replication/tran-
scription balance. In this system, synthesis of the viral pro-
teins is driven by the Cytomegalovirus immediately early
promoter and is thus uncoupled from the levels of tran-
scription and replication of the viral RNAs. 293T cells
were co-transfected with plasmids that separately
expressed the three polymerase proteins, NP (all from
influenza virus PR8) and a model v- or cRNA segment
containing a chloramphenicol acetyltransferase (CAT)
gene. Cells were then incubated at 31°C, 37°C or 39°C
for three days and total cellular RNA isolated. The viral
RNA species synthesized by recombinant RNPs at the dif-
ferent temperatures were analysed by primer-extension
assay. No products were observed from cells transfected
with all plasmids except PB1 (Fig. 2A, lanes 4–6 and 10–
12). When cells expressed the complete set of RNP
polypeptides and either the positive or negative-sense
model segment, primer extension products of the pre-
dicted sizes [20] for viral m-, c-, and vRNA were detected
at all incubation temperatures (Fig. 2A lanes 1–3 and 7–
9), indicating that the recombinant RNPs were active for
both transcription and replication. However, it was clear
that as the incubation temperature increased from 31°C
to 39°C the amount of replicative RNA products (c- and
vRNA) decreased and a greater accumulation of mRNA
was observed. This change from replication to transcrip-
tion with increasing temperature was not altered by the
sense of the model virus segment used to seed the reac-
tions, as all three viral RNA species altered in abundance
as temperature was varied, with both (+) and (-) CAT-
primed reactions. When radiolabeled products were
quantified by densitometry in replicate experiments the
trend was confirmed (Fig. 2B). In experiments where a
negative polarity CAT segment was introduced, the ratios
of cRNA to mRNA and vRNA to mRNA changed by
around 8 fold across the temperature range. When a
cRNA-like CAT RNA was transfected the cRNA:mRNA
ratio decreased by over 3-fold and the vRNA:mRNA ratio
decreased by 10-fold or greater as incubation temperature
was shifted from 31°C to 39°C. Furthermore, the temper-
ature sensitivity was not an artefact of the particular cDNA
clones used, as similar effects were noted when RNPs were
reconstructed with clones from another human influenza
virus, A/Victoria/75, and when authentic influenza seg-
ments from A/WSN/33 strain were produced from reverse
genetic plasmids (data not shown).Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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The synthesis of NP and PB1 in transfected cells at the dif-
ferent incubation temperatures was analysed by western
blotting. Temperature did not significantly alter the accu-
mulation of either viral protein relative to a constitutively
expressed cellular protein not known to be affected by
temperature (Fig. 2C compare lanes 2–5 to 6–9). This sug-
gests that similarly to authentic viral infection, alterations
to the expression levels of viral proteins do not explain the
temperature dependent change in the balance between
viral transcription and replication.
Thus, the balance between transcription and replication
of the influenza virus genome is affected by temperature
in the settings of both infection and transfection,
although a wider range of temperature affects the latter
system.
Heat shock proteins as potential factors in the 
temperature-dependent inhibition of viral genome 
replication
Heat shock protein (hsp) synthesis and activity plays an
important role in the cellular response to stress condi-
tions, such as high temperature [42,43]. Several reports
have indicated an interaction between hsps and influenza
virus RNP components. Hsp70 has been reported to inter-
act with NP at 41°C and to consequently block vRNP
nuclear export [41]. Since NP is also intimately involved
in viral RNA synthesis [1] it is possible that this cellular
interaction might influence vRNA replication. Similarly,
hsp90 has been suggested to bind two or more of the
polymerase subunits at 37°C, with possible stimulatory
or inhibitory effects on virus RNA synthesis [26,30]. We
therefore tested the hypothesis that hsp activity was
responsible for the down-regulation of vRNA synthesis at
41°C.
First, to test for a correlation between hsp induction and
the decrease in viral RNA replication, 293T cells were
heated at 41°C for 4 hours to induce hsp synthesis,
infected with influenza virus and incubated at 37°C for a
further 5 hours. Western blotting confirmed that both
hsp70 and hsp90 synthesis were induced by incubation at
41°C and that the same high levels were maintained for at
least another 5 hours at 37°C (data not shown, but see
later). Non-preheated cells were also infected and incu-
bated at either 37°C or 41°C for 5 hours as controls. Total
cellular RNA was isolated and primer extensions per-
formed to analyse viral RNA synthesis from segments 2, 5
and 7. As previously observed, when cells were infected
and incubated at 41°C for 5 hours, vRNA accumulation
was reduced compared to 37°C (Fig. 3A, lanes 2 and 3).
Also as before, NP and M1 mRNA levels were similar in
cells incubated at either temperature, while PB1 mRNA
was increased at 41°C. However, synthesis of vRNA in the
pre-heated cells was comparable to that observed at 37°C
Effect of temperature on the activity of reconstituted influ- enza virus RNPs Figure 2
Effect of temperature on the activity of reconstituted 
influenza virus RNPs. 293T cells were transfected with 
plasmids for the expression of PB1, PB2, PA and NP (3PNP) 
and either pPol-I(-)NSCAT (-CAT) or pPol-I(+)NSCAT 
(+CAT) or the same without PB1 (-PB1). Cells were incu-
bated at 31°C, 37°C or 39°C as indicated for three days. A. 
Total cellular RNA was isolated and subjected to primer 
extension analysis for virus-derived CAT m-, c- and vRNA, as 
labelled. Products of primer extension analysis were sepa-
rated by 6% denaturing PAGE and detected by autoradiogra-
phy. The open arrowhead indicates a truncated product 
derived from vRNA. B. Radiolabeled products for m- c. and 
vRNA were quantified by densitometry. The ratios of 
cRNA:mRNA and vRNA:mRNA were calculated and are 
shown as the fold change (average ± S.D.) in ratios between 
31°C and 39°C for cells seeded with vRNA (-CAT) (n = 3) 
and cRNA (+CAT) (n = 6). C. Doubling dilutions (up to 1/8) 
of total cell lysates were analysed by electrophoresis and 
western blotting to detect PB1, NP and clathrin. Purified viri-
ons were also included to provide a size marker for viral pro-
teins (lane 1).Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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(Fig. 3A, compare lanes 5 to 2 and 3). Induction of hsp70
has been associated with the inhibition of RNP nuclear
export [41]. However, while immunofluorescence analy-
sis confirmed nuclear retention of NP at 41°C, pre-heated
cells presented a cytoplasmic localization pattern for NP,
similar to the expected late staining pattern [44] observed
in non-preheated cells infected at 37°C (Fig. 3B). Similar
results were obtained when the experiments were carried
out in MDCK cells (data not shown). Overall, neither
genome replication nor RNP nuclear export were inhib-
ited in infections carried out at 37°C, even in the presence
of hsps synthesised during a prior heat shock at 41°C.
Thus, hsp induction by itself is not sufficient to alter the
replication/transcription balance of the virus.
Effect of pre-heating cells on viral infection Figure 3
Effect of pre-heating cells on viral infection. 293T cells were incubated at 41°C for 4 h prior to infection with PR8 virus 
(I Pre) or mock-infection (M Pre), and incubated for 5 h at 37°C. Cells infected (I) or mock-infected (M) and incubated at 37°C 
or 41°C served as controls. A. Total RNA was isolated and subjected to radiolabelled primer extension analysis to detect seg-
ment 5, 7 and 2-specific RNA. B. Cells were fixed at 5 hpi and analysed by confocal microscopy after staining for NP (green) 
and LAP-2 to delineate the nucleus (red). Bars 10 μm.Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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Although hsp induction does not down-regulate vRNA
synthesis at 37°C, a temperature-dependent activity of
hsps could be involved. For example, during heat shock
hsp90 oligomerizes with the possible activation of func-
tions that are normally silent at physiological temperature
[45]. To test this hypothesis two drugs that interfere with
hsp responses were used. First, quercetin was used to
inhibit hsp70 synthesis [46,47]. MDCK cells were infected
and treated or mock-treated with 30 μM quercetin for 5
hours at either 37°C or 41°C. Western blot analysis of
hsp70 (using an antibody that recognises the constitu-
tively expressed 72 kDa hsc70 and the 70 kDa inducible
hsp70 [43]) showed an induction of this protein at 41°C
in both mock-infected and infected cells (Fig. 4A, com-
pare lanes 1 to 5 and 3 to 7). However, hsp70 levels were
markedly lower when cells were treated with quercetin
compared to untreated cells (compare lane 5 to 6 and 7 to
8). Nevertheless, primer extension analysis for segments 2
and 5 showed that the levels of vRNA accumulation in
infected-cells incubated at 41°C remained substantially
lower than at 37°C, even with quercetin treatment (Fig.
4B, compare lane 3 to 7 and 4 to 8). The levels of c- and
mRNA were also similar in treated and untreated cells
(data not shown).
Next, geldanamycin was used to interfere with hsp90
function. Hsp90 participates in two multichaperone com-
plexes with opposing activities depending on the co-chap-
erone proteins attached to it. In one conformation the
hsp90 complex binds to and stabilizes its client proteins,
in the other, it promotes client protein ubiquitination and
degradation by the proteasome. Geldanamycin binds to
hsp90 and forces it to adopt the conformation that
favours proteasome-targeting and prevents the stabiliza-
tion function [48]. 293T cells were inoculated with influ-
enza virus and incubated at either 37°C or 41°C for 5
hours. Cells were either mock-treated or treated with 20 or
30 ng/ml of geldanamycin immediately after the virus
adsorption period. Western blot analysis of the cell lysates
showed decreasing levels of PB2 as the concentration of
geldanamycin was increased at either temperature (Fig.
4C, lanes 3–5 and 8–10). This is consistent with a PB2-
hsp90 interaction [30] that in the presence of geldanamy-
cin results in the degradation of the client protein. Primer
extension analysis for segment 2 was carried out on total
cellular RNA extracted from these samples to test viral
RNA synthesis during drug treatment. As previously
observed for segment 2, levels of vRNA accumulation
were lower, and those of mRNA higher, at 41°C com-
pared to 37°C in non-treated cells (Fig. 4D, compare lane
3 to 8). However, when cells infected at 41°C were treated
Effect of chemical inhibition of heat shock responses on viral RNA synthesis Figure 4
Effect of chemical inhibition of heat shock responses on viral RNA synthesis. A, B. Inhibition of hsp70 synthesis by 
quercetin. MDCK cells were infected (I) or mock-infected (M) with PR8 virus, treated (+) or mock-treated (-) with 30 μM 
quercetin and incubated at 37°C or 41°C for 5 h. A. Cell lysates were analysed by SDS-PAGE and Western blotting to detect 
hsp70/hsc70 and, as a loading control, β-actin. B. Total RNA was isolated and primer extension analysis was carried out to 
detect segment 5 and 2 vRNA. C, D. Inhibition of hsp90 chaperone function by geldanamycin. 293T cells were infected (I) or 
mock-infected (M) with PR8 virus, treated with 0, 20 or 30 ng/ml of geldanamycin (as indicated) and incubated at 37°C or 41°C 
for 5 h. C. Cell lysates were analysed by Western blotting to detect PB2 and, as a loading control, LAP-2 proteins. D. Total 
RNA was analysed by primer extension to detect segment 2-specific RNA.Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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with either 20 or 30 ng/ml of geldanamycin the levels of
vRNA remained low and in fact were further decreased by
the drug (compare lanes 4 and 5 to 9 and 10).
Thus, at 41°C viral genome replication cannot be rescued
by inhibiting hsp70 synthesis or hsp90 chaperone func-
tion, providing no support for the hypothesis that either
of these cellular proteins is responsible for down-regula-
tion of vRNA synthesis at high temperature, despite their
known interactions with RNP components.
Analysis of the effect of temperature on RNP formation
A previous study suggested that RNP formation in infected
cells was not impaired at 41°C on the basis of the glycerol
density gradient centrifugation profile of NP [49].
Although glycerol gradients are often used to purify virion
associated RNPs away from membrane and other low
density virion components [17] we decided to employ
velocity gradients to analyse RNP formation on the
grounds that a technique that separates according to
molecular weight might provide a more sensitive test.
Accordingly, cell lysates prepared from infected cells incu-
bated at 37°C or 41°C were separated by sucrose gradient
centrifugation and the individual fractions analysed for
protein and RNA content. Western blot analysis of NP
showed two peaks from cells incubated at 37°C; a fast
sedimenting fraction at the bottom of the gradient and a
slower migrating fraction towards the middle (Fig. 5a).
When PB1 was examined as a marker for the viral
polymerase, this was mostly found as a fast-sedimenting
species towards the bottom of the gradient (Fig. 5c). Anal-
ysis of segment 7 RNA content showed that these fast-sed-
imenting pools of PB1 and NP were associated with both
v- and cRNA (Fig. 5 e, f). This indicates that these bottom
fractions contain RNPs while the slower migrating pool of
NP represents unassembled material. Similar results were
obtained for segments 2 and 5 except that they sedi-
mented 1 to 3 fractions further down the gradient (data
not shown). When material from cells incubated at 41°C
was analysed, the amount of fast-sedimenting NP was
much reduced and the pool of material around the mid-
dle of the gradient was shifted slightly further up the gra-
dient (Fig. 5b). The reduced amounts of fast-sedimenting
NP were still associated with detectable v- and cRNA (Fig.
5 g, h, although vRNA in particular was present in much
reduced amounts compared to 37°C, consistent with
analysis of total RNA content. However, no polymerase
was detectable in these high molecular weight fractions
(Fig. 5d). Polymerase not assembled onto RNPs was not
detected in the slower sedimenting fractions but instead
partitioned with insoluble cell nuclear material removed
from the lysates by low speed centrifugation before load-
ing the gradient (data not shown). Overall therefore, we
conclude there is a defect in vRNA synthesis at 41°C that
results in reduced quantities of RNPs that are also defi-
cient in polymerase content.
Prior work has shown that in vitro, ApG primed transcrip-
tional activity of the polymerase is unstable at 40°C in the
absence of vRNA [50]. As our results suggested that the
viral polymerase does not remain bound to RNPs at 41°C,
we tested the activity of the polymerase under these con-
ditions by temperature shift experiments. Duplicate cell
cultures were inoculated with influenza virus and incu-
bated at either 37°C or 41°C for 4 hours. At this point
cycloheximide was added to one set of experiments to
inhibit protein synthesis and therefore permit the tran-
scriptional activity of polymerase synthesised during the
preceding 4 h to be examined in isolation. However, this
strategy only works for mRNA synthesis as cycloheximide
inhibits genome replication [11,13,51]. The incubation
temperature was shifted up or down and infections
allowed to proceed for another 4 hours. Control experi-
ments where the temperature was not altered during 8
hours or in which cells were harvested at 4 hours post-
infection were also performed. At 8 hours post-infection
cell lysates were harvested and segment 7 synthesis exam-
Analysis of RNP formation at different temperatures Figure 5
Analysis of RNP formation at different temperatures. 
Infected 293T cells were incubated at 37°C or 41°C for 5 h 
and lysed as described in Methods. The extracts were lay-
ered onto 5–20% sucrose gradients and separated by centrif-
ugation. The resulting fractions were analysed by Western 
blotting to detect (a, b) NP and (c, d) PB1. (e-h) RNA was 
also extracted from each fraction and subjected to primer 
extension analysis to detect segment 7-specific RNA.Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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ined. No virus-specific products were observed from
mock-infected cell lysates (Fig. 6, lanes 11 and 12). At
37°C levels of mRNA decreased and vRNA increased
between 4 and 8 h p.i. (Fig. 6, compare lane 1 to 3). At
41°C, mRNA and vRNA levels increased with time (com-
pare lanes 2 and 5) but vRNA accumulation was much
decreased compared to 37°C (compare lanes 3 and 5). As
previously described [51], when cycloheximide was added
after 4 hpi, levels of mRNA were boosted compared to
untreated cells and vRNA synthesis was inhibited at either
37°C or 41°C (compare lanes 3 to 4 and 5 to 6). When
temperature was shifted up after 4 hpi, accumulation of
vRNA stopped (compare lanes 1, 3 and 7). This suggests
that polymerase formed at 37°C during the first 4 hours is
not capable of synthesising vRNA once placed at 41°C.
However, viral RNA synthesis was not globally inhibited
as high levels of mRNA were observed in shifted up cells
treated with cycloheximide (lane 8). Conversely, when
temperature was shifted down after 4 hpi vRNA accumu-
lation recovered (Fig. 6, compare lanes 2, 5 and 9). Similar
overall results were observed for segments 2 and 5 (data
not shown). Overall, this indicates that at high tempera-
ture the viral polymerase is highly transcriptionally active
but defective for vRNA synthesis and this temperature
dependent switch in activity acts on RNA synthesis itself,
not when the polymerase is translated.
Stability of polymerase-template interactions at elevated 
temperature
Given our observations of heat stable transcriptionally
active polymerase and near normal accumulation of plus-
sense RNA species coupled with a specific defect in vRNA
synthesis, we hypothesised that the interaction of
polymerase with its cRNA template might be particularly
temperature sensitive [52,53]. The interaction of trimeric
polymerase with promoter RNAs was therefore tested at
the appropriate temperatures using a bandshift assay
based on recombinant polymerase expressed from vac-
cinia virus and short synthetic v- and cRNA panhandle
RNAs [24]. When nuclear extracts containing the influ-
enza virus polymerase were tested, a low electrophoretic
mobility radiolabelled complex was observed for both v-
and c-RNA (Fig. 7, lane 3). No complex was observed
when nuclear extracts containing bacteriophage T7 RNA
polymerase were examined (Fig. 7A, B; lanes 1 and 2). To
measure the dissociation rate of the polymerase-panhan-
dle interaction, complexes were allowed to form at room
temperature, then heparin was added and the binding
reactions incubated at 31, 37 or 41°C for varying lengths
of time before analysis. Heparin effectively prevents the
initial binding of the polymerase to the template RNA,
thus it can be used to prevent reassociation of the
polymerase during a dissociation experiment [24,54]. At
31°C, polymerase-panhandle complexes were stable over
the time-course examined, for both v- and cRNA (Fig. 7A,
B; lanes 12–15). At 41°C, polymerase-promoter RNA
complexes were unstable, with both v- and cRNA com-
plexes showing significant amounts of dissociation by 40
minutes (Fig. 7A, B; lanes 4 – 7). However, polymerase-
cRNA complexes were clearly less stable than the equiva-
lent vRNA structure. Replicate experiments determined
the t1/2 for dissociation of the polymerase at 41°C to be
around 10 minutes for cRNA but greater than 40 minutes
for vRNA (Fig. 7C). Furthermore, when dissociation was
examined at 37°C, polymerase-vRNA complexes were
essentially stable but nearly half of the polymerase mole-
cules initially bound to cRNA had dissociated after 40
minutes (Fig. 7A, B; lanes 8–11, Fig. 7C). These data indi-
cate that the interaction of the influenza virus polymerase
with cRNA promoter is indeed significantly less stable at
elevated temperatures than the interaction with the vRNA
counterpart. This suggests that negative strand synthesis
fails at high temperature simply because the polymerase is
unable to productively interact with the appropriate pro-
moter.
To further analyse this hypothesis, we tested whether
mutations in the cRNA promoter that render it more
Effect of temperature on viral polymerase activity Figure 6
Effect of temperature on viral polymerase activity. 
293T cells were infected with PR8 virus and incubated at 
37°C or 41°C for 4 h. At this point 50 μg/ml of cyclohex-
imide (+) or the same volume of DMSO (-) was added to the 
cells, temperature was shifted up (lanes 7, 8) or down (lanes 
9, 10) and infections left to proceed for another 4 h. Total 
RNA was isolated and primer extension was carried out to 
detect segment 7-specific RNAs as labelled. Infected cells 
incubated at 37°C or 41°C for 4 h (lanes 1, 2) or 8 h (lanes 3, 
4 and 5, 6 respectively) served as positive controls. Mock-
infected cells incubated at 37°C for 8 h served as a negative 
control (lanes 11, 12).Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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vRNA-like would rescue normal viral genome replication
at high temperature. For this, we utilised two mutants in
which either the 5'-end (3'U-8'A) or the 3'-end (3G-8C) of
the cRNA promoter was altered [55]. 293T cells were co-
transfected with plasmids that expressed the three
polymerase proteins, NP and wild-type (WT) or mutant
model cRNA segments containing a CAT gene. Cells were
then incubated either at 31°C, 37°C or 39°C for three
days and viral RNA accumulation analyzed. No products
were observed from cells that were transfected with all
plasmids except PB1 (Fig. 8A, lanes 1–3). When cells
expressed the complete set of RNP polypeptides and the
wild type positive-sense model segment, the amount of
replicative RNA products (c- and vRNA) decreased sharply
at 37°C, whereas accumulation of mRNA increased as the
incubation temperature was raised from 31°C to 39°C
(Fig. 8A, lanes 4–6), as shown before. The same pattern of
temperature dependent viral RNA synthesis was observed
when a cRNA segment with the 3G-8C mutation in its 3'-
end was transfected (lanes 10–12). When the 5'-end 3'U-
8'A mutant was used, lower levels of mRNA and higher of
cRNA were observed compared to the wild type segment
(Fig. 8A, compare lanes 7–9 to 4–6), as previously
described [55]. Significantly however, synthesis of c- and
vRNA was less affected by increasing temperature when
using the 5'-end mutant and mRNA synthesis did not
increase with temperature as dramatically as when wild
type cRNA was used (lanes 7–9, compare to lanes 4–6).
Radiolabeled products obtained with the three different
promoters (WT, 3'U-8'A and 3G-8C) were quantified by
densitometry in replicate experiments. When cells were
incubated at either 37°C or 39°C, the ratio of vRNA to
mRNA increased by around 10 fold when cRNA segment
was mutated in its 5'-end, compared to both WT and 3'-
end mutated promoter (Fig. 8B). Thus the balance
between transcription and replication catalysed by WT
polymerase becomes less temperature sensitive when sup-
plied with a hybrid cRNA promoter containing mutations
in the 5'- but not 3'-end. Since the primary interaction of
the polymerase with the cRNA promoter occurs with the
5'-end of the structure [53], this finding supports our
hypothesis that temperature sensitive genome replication
results from heat-labile polymerase binding to the plus-
strand template.
Discussion
Here, we show that temperature dramatically affects the
balance between transcription and replication of the
Effect of temperature on the dissociation of viral polymerase-RNA complexes Figure 7
Effect of temperature on the dissociation of viral polymerase-RNA complexes. Nuclear extracts containing the bac-
teriophage T7 RNA polymerase (T7) or the influenza virus polymerase (3P) were bound at room temperature for 10 min to 
(a) radiolabelled vRNA or (b) cRNA molecules and incubated at 31, 37 or 41 °C for the indicated periods of time in the pres-
ence of heparin before analysis by non-denaturing PAGE and autoradiography. (c) The amounts of polymerase-template com-
plexes were quantified by densitometry and expressed as the fraction of complex remaining compared to T0. The average and 
range of two independent experiments is plotted.Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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Effect of cRNA promoter mutations on temperature sensitive vRNA synthesis Figure 8
Effect of cRNA promoter mutations on temperature sensitive vRNA synthesis. 293T cells were transfected and 
incubated as described for figure 2, using either a wild type pPol-I(+)NSCAT or two promoter mutants that transplant a 
vRNA-like base pair into the cRNA promoter; mutants 3'U-8'A (5'-end) or 3G-8C (3'-end). A. Total RNA was harvested and 
analyzed by primer extension as described before to detect virus-derived CAT RNA species. B. Radiolabelled products for m- 
and vRNA were quantified by densitometry. Mean ratio of vRNA:mRNA at 37°C and 39°C from two independent experiments 
is plotted.Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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influenza virus genome, with high temperature in partic-
ular favouring mRNA production over vRNA synthesis
(Figs. 1 and 2). This effect was observed for both recom-
binant and authentic viral RNPs, for three strains of viral
RNPs and in two different cell types, suggesting it is a gen-
eral phenomenon for mammalian-adapted influenza A
virus replication. The down regulation of vRNA synthesis
at high temperature did not result from a deficiency of a
viral polypeptide necessary for genome replication as no
significant reduction was seen in the quantities of any of
the viral proteins (Figs. 1, 2, 4 and data not shown).
Although a recent report has suggested that NS1 is a nec-
essary co-factor for vRNA synthesis [56], we found no
defect in NS1 translation (Fig. 1C) and NS1 is clearly not
required for replication in the recombinant system (Fig.
2). It was necessary to address the hypothesis that cellular
heat shock proteins were responsible for the reduction in
vRNA synthesis, as previous reports have indicated that
hsp90 interacts with both PB2 and PB1-PA complexes at
37°C [26,30] and that hsp70 binds NP at 37°C and 41°C
[41]. In vitro at 30°C, hsp90 stimulates ApG-primed tran-
scription of an exogenous template added to virion-
derived RNPs, while hsp70 has little effect [30]. An inter-
action of hsp70 with NP has however been proposed to
block M1-RNP interactions and consequently inhibit RNP
nuclear export [41]. However, the temperature dependent
inhibition of genome replication showed no correlation
with the amount of hsp70 and hsp90 present in cells.
Heat shock prior to infection to induce hsp synthesis did
not alter viral RNA synthesis at 37°C (Fig. 3). Further-
more, inhibition of hsp70 induction with quercetin did
not rescue vRNA synthesis at 41°C (Fig. 4A). Similarly,
geldanamycin-mediated inhibition of the chaperone
function of hsp90 failed to rescue vRNA synthesis at 41°C
(Fig. 4B). Hirayama et al. (2004) showed that in infected
MDCK cells prostaglandin A1 (PGA) blocks NP nuclear
export at 37°C and induces hsp70 expression without
inhibiting viral gene expression. However, in 293-T cells
we found that PGA inhibited all forms of viral RNA syn-
thesis and viral protein expression (data not shown).
Other studies have also noted inhibition of influenza
virus gene expression by PGA and other prostaglandins
and related compounds that induce hsp70 as well as a
variety of other stress-related polypeptides [57,58]. Over-
all therefore, although it is difficult to rule out categori-
cally, we find no evidence in favour of the hypothesis that
cellular hsp70 and/or 90 mediate the inhibition of viral
genome replication at high temperature.
Two observations relating to the effects of hsps on virus
replication are worthy of further comment. Firstly, while
previous observations [41,49] regarding the inhibition of
NP nuclear export at 41°C were confirmed (Fig. 3), RNP
formation was found to be abnormal, whereas the study
of Sakaguchi et al (2003) [49] noted unaltered NP sedi-
mentation behaviour on glycerol density gradients. The
discrepancy between the two studies may result from the
different gradient fractionation methods employed and
the fact that Sakaguchi et al. looked solely at NP sedimen-
tation and not RNA and polymerase protein sedimenta-
tion in addition to NP (reported here), which provides a
more rigorous test of RNP formation (Fig. 5). Therefore,
another contributing factor to the failure of NP nuclear
export at 41°C is that RNP formation is much reduced.
Secondly, the observation that moderate concentrations
of geldanamycin inhibit PB2 accumulation at 37°C and
41°C, which is consistent with prior data indicating an
interaction between this viral protein and hsp90 [26,30]
raises the possibility that geldanamycin may have antivi-
ral activity against influenza A as well as a variety of other
viruses [59-62].
Although temperature sensitive interactions with cellular
components other than hsp proteins cannot be ruled out
it is appropriate to consider explanations for the loss of
vRNA synthesis at high temperature that are intrinsic to
the viral components themselves. Temperature-shift
cycloheximide block experiments showed that the key
determinant that lead to a failure of vRNA synthesis was
high temperature during RNA synthesis, and not during
polymerase translation, and that polymerase synthesised
at 41°C retained the ability to synthesise mRNA at 37°C
and 41°C (Fig. 6). Furthermore, in vitro, there is a clear
difference in the thermal sensitivity of polymerase-vRNA
and polymerase-cRNA complexes (Fig. 7). This finding
suggests a simple model that explains our results. At 41°C
the polymerase shows a slow rate of dissociation from
vRNA (Fig. 7). At least a proportion of the polymerase that
dissociates from v- or cRNA at 41°C has been found to be
capable of rebinding to its template (data not shown). We
hypothesise therefore that an equilibrium exists between
polymerase and vRNA at 41°C that permits substantial
amounts of mRNA and cRNA synthesis (Fig 9). However,
the far higher rate of dissociation from cRNA at elevated
temperature biases the equilibrium further away from
mature cRNP formation and leads to a proportionally
greater defect in vRNA synthesis (Fig. 9). In support of this
hypothesis, a cRNA promoter mutation that makes it
more similar to the vRNA structure reduced the effect of
high temperature on vRNA synthesis (Fig. 8).
The two-fold reduction in cRNA accumulation at 41°C
might result from a reduced rate of synthesis, or from
increased degradation of "naked" cRNPs, consistent with
a recently suggested hypothesis for how cRNA synthesis is
regulated [21]. Increased degradation rates of RNPs may
explain the apparently greater thermal sensitivity of
recombinant RNPs (Figs. 2 and 8) because of the much
longer timeframe of these assays (3 days compared to ≤ 8
h). The apparent paradox between increased levels ofVirology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
Page 13 of 16
(page number not for citation purposes)
mRNA synthesis in the face of reduced vRNA levels may
result from a higher rate of transcription of a reduced
number of template molecules. This might reflect a Q10
effect of the higher temperature but may also result from
loss of normal regulatory patterns (such as nuclear export
of vRNA) during viral transcription. Consistent with the
latter possibility, previous studies have noted substantial
levels of mRNA transcription from a limited number of
input vRNA templates when genome replication is
blocked by cycloheximide [11,12,63].
At 37°C our finding that there is a negligible dissociation
rate between polymerase and vRNA is consistent with the
currently accepted mechanism for polyadenylation. In
this hypothesis, the polymerase remains bound to the 5'-
end of vRNA throughout mRNA transcription, thus forc-
ing non-processive copying of a poly(U) stretch adjacent
to the polymerase-binding site [6,7,54,64,65]. In light of
recent research indicating that RNPs localise to specific
regions within the nucleus [66,67], a mechanism whereby
vRNA molecules can be reiteratively copied without
release of the polymerase seems likely to increase the effi-
ciency of template usage. The significantly higher dissoci-
ation rate for polymerase-cRNA complexes at 37°C
reflects a weaker interaction of the polymerase with the 5'-
end of cRNA. This is consistent with the need to synthesise
only full length copies from this template which presum-
ably requires a template release step for each cycle of
vRNA synthesis (Fig. 9). This is perhaps surprising given
that large amounts of vRNA molecules are manufactured
from a limited number of cRNAs whose synthesis appar-
ently ceases early in infection [5,68]. However, this quan-
titative difference in how the polymerase interacts with c-
and vRNA promoters is consistent with recent research
suggesting a qualitative difference in the mechanism used
to initiate unprimed (replicative) transcription from the
two strands [69].
Conclusion
Human influenza A virus, genome RNA synthesis is inhib-
ited at high temperature, with transcription strongly
favoured over replication. This temperature effect is due to
the differential stability of negative and positive sense
polymerase-promoter complexes, which is accentuated at
high temperature (fig. 9). These findings have implica-
tions for the mechanisms that control normal viral RNA
synthesis. Furthermore, as temperature is a notable physi-
ological difference between avian and mammalian host
systems, such considerations may have significance for
the influence of avian virus-derived polymerase genes on
host range and pathogenesis.
Methods
Cells, virus, plasmids, antibodies and other compounds
Human embryonic kidney 293T cells and Madin-Darby
canine kidney (MDCK) cells were cultured in Dulbecco's
modified Eagle's medium supplemented with L-
glutamine, penicillin, streptomycin and 10% fetal calf
serum (FCS). Influenza virus strain PR8 was propagated in
10-day-old embryonated eggs as described previously
[70]. Infections were carried out at a m.o.i. of 5 and gen-
erally harvested at 5 h.p.i.
Plasmids pcDNA-PB2, -PB1, -PA and -NP are described
elsewhere [20,44]. pPolI(-)NS.CAT.RT, containing an
antisense CAT gene flanked by the non-coding sequences
of influenza A/WSN/33 virus segment 8, under control of
a human RNA polymerase I promoter (Pol-I) and
upstream of a hepatitis δ ribozyme sequence, was gener-
ously provided by Ervin Fodor (University of Oxford). A
similar positive-sense CAT reporter [pPol-I(+)NS.CAT]
has also been previously described [20]. Plasmids pPOLI-
cCAT-RT wild type, 3'U-8'A mutant (C-G to U-A in 5'-end)
and 3G-8C mutant (A-U to G-C in 3'-end) were kindly
provided by G. Brownlee [55]. Plasmids p5'3'v and p5'3'c
contain the T7 RNA polymerase promoter immediately
upstream of model vRNA and cRNA template sequences
such that linearization with MboII and transcription with
T7 RNA polymerase leads to the synthesis of run-off tran-




Cartoon model of the effect of temperature on polymerase- RNP interactions and viral RNA synthesis Figure 9
Cartoon model of the effect of temperature on 
polymerase-RNP interactions and viral RNA synthe-
sis. The size of arrow represents the relative rate of each 
process. At 37°C, polymerase-vRNA complexes are stable 
and catalyse the synthesis of mRNA and low amounts of 
cRNA. Polymerase-cRNA complexes show a moderate rate 
of dissociation and reassociation that permits high levels of 
vRNA synthesis. At 41°C, polymerase-vRNA complexes are 
less stable but still permit high level mRNA synthesis and 
near normal cRNA synthesis. However, the high rate with 
which polymerase-cRNA complexes dissociate does not per-
mit efficient vRNA synthesis.Virology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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underlined bold sequences correspond to the terminal
regions of segment 8 (NS1) vRNA and cRNA respectively.
Nuclear extracts of HeLa cells co-infected with vaccinia
recombinants expressing the PB1, PB2 and PA subunits of
the PR8 polymerase (Vac3P) were prepared as described
previously [54].
Rabbit polyclonal antisera to influenza A virus RNP and
anti-PR8 PB2 (MBP-PB2-C), PB1 (PB1-F1) and PA (PA-
F3) have been described previously [19,71]. Mouse mon-
oclonal anti-PB1 (aa 44–69) was kindly provided by Dr.
Mark Krystal (Bristol-Myers Squibb). Antibodies to β-
actin, Lamin associated polypeptide 2 (LAP-2) and clath-
rin heavy chain were purchased from Sigma-Aldrich, Bio-
sciences Pharmingen and Santa Cruz, respectively.
Antibody to hsc72/hsp70 was supplied by BD Bioscience.
Anti-rabbit IgG antibody conjugated to fluorescein isothi-
ocyanate was supplied by DAKO A/S and Alexa 594-con-
jugated anti-mouse IgG antibodies by Molecular Probes.
HRP-conjugated anti-rabbit or mouse IgG was purchased
from Amersham Biosciences.
Quercetin was purchased from Calbiochem and cyclohex-
imide and geldanamycin from Sigma. Drugs were dis-
solved in dimethylsulfoxide (DMSO) and stored at -20°C,
except quercetin, which was stored at 4°C.
Influenza virus gene-expression assay
To reconstitute RNPs, 1 × 106 293-T cells per 35 mm well
in 1 ml complete medium were transfected in suspension
with 0.25 μg each of pcDNA-PB1, -PB2, -PA and -NP and
50 ng of either pPolI(+) NS.CAT, pPolI(-)NS.CAT.RT, 3'-
8' mutant or 3–8 mutant, using cationic liposomes (Lipo-
fectin; Gibco-BRL). The total amount of DNA in each
transfection mix was normalized by the addition of
pcDNA3 vector. Transfected cells were incubated for three
days before harvest [20].
Primer-extension analysis of viral RNA
Total cellular RNA was isolated using a commercial kit (SV
Total RNA Isolation System; Promega) according to the
manufacturer's instructions. After spectrophotometric
quantification and normalization, RNA was reverse-tran-
scribed using avian myeloblastosis virus reverse tran-
scriptase (Promega) and the appropriate DNA
oligonucleotides that had been 5' end-labelled with [γ-
32P]ATP as previously described [20]. Radiolabelled prod-
ucts were detected by autoradiography and quantified by
densitometry using NIH Image software [72]. The oligo-
nucleotides used were 5'-GAACTGAGCAACCTTGCG-3'
(for detection of vRNA-sense segment 1), 5'-GTACTTCTT-
GATTATGGC-3' (positive-sense segment 1), 5'-TCCAG-
TATGGTGGAGGC-3' (vRNA-sense segment 2), 5'-
GTATCCTGTTCCTGTCCC-3' (positive-sense segment 2),
5'-CAAATAACATTTATGCAAGCC-3' (vRNA-sense seg-
ment 8) and 5'-TTAGGGATTTCTGATCTCGGC-3' (posi-
tive-sense segment 8). The oligonucleotides used to detect
segments, 5, 7 and CAT have been previously described
[20].
Protein analysis
For Western blots, cell lysates were separated by SDS-
PAGE and transferred to nitrocellulose. Blots were probed
with primary followed by secondary antibodies conju-
gated to horse-radish peroxidase (DAKO) and developed
by chemiluminescence (ECL reagent; Amersham Bio-
sciences). Immunofluorescence assays were carried out as
previously described [70,44]. For metabolic labelling of
proteins, 293T cells were washed twice with methionine-
free medium for 5 min. and then incubated for 2 h with
60 nCi/μl of 35S-methionine For immunoprecipitation, 4
× 105 cells were labelled at 4 hpi as described above, then
harvested in 200 μl IP buffer (50 mM Tris-HCl, pH7.6,
100 mM KCl, 5 mM MgCl2) containing 0.1% NP40 before
being subjected to immunoprecipitation as previously
described [73].
Velocity gradient centrifugation
8 × 106 293T cells were lysed with 1 ml of buffer contain-
ing 0.5% Triton X-100, 10 mM NaCl and 20 mM Tris-HCl
(pH7.6), treated with 10 μg/ml Dnase I (Sigma), 5 mM
MgCl2, 10 mM vanadyl ribonucleoside complex (New
England Biolabs) for 15 min at 37°C and clarified at
3,000 rpm for 5 min at 4°C in a minicentrifuge. The
supernatant was layered on top of a 12 ml continuous 5–
20% (w/v) sucrose gradient in 20 mM Tris-Cl pH7.6, 50
mM NaCl, 0.1 mM EDTA and centrifuged at 100,000 gav
for 13 h [73]. Fractions were then collected and analysed
for their protein and RNA content by western blot and
primer extension respectively. For this, protein was con-
centrated by precipitation with methanol-chloroform
[74] and RNA was isolated by phenol:chloroform extrac-
tion and ethanol precipitation.
Polymerase binding assays
The preparation of RNA transcripts labelled internally
with [α-32P] GTP and the binding assay protocol have
been described previously [54]. 150 μl binding reactions
containing 1.5 × 105 cpm of labelled probe (5'3'v or 5'3'c)
were incubated with 30 μg of Vac 3P extract for 10 min at
22°C to allow the polymerase to bind to the RNA.
Heparin was then added to a final concentration of 5 mg/
ml, sufficient to inhibit all subsequent binding of the
polymerase and displace non-specific RNA binding of
other proteins in the extract. The binding reactions were
then aliquoted into 12 separate tubes and incubated at
either 31°C, 37°C or 41°C. At regular intervals, one tube
from each temperature was removed and placed on ice
until the completion of the time course. The samples wereVirology Journal 2006, 3:58 http://www.virologyj.com/content/3/1/58
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then analysed by non-denaturing electrophoresis and
autoradiography as described previously [54].
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